Some of the most influential leaders in European healthcare have been in London for key discussions on the sector's future.
The Economist Events’ Value-based Healthcare in Europe 2016 focused on how global health systems need to adapt to the unprecedented rate of medical and technological innovation revolutionizing the industry.
Potential advantages and practical difficulties in implementing a value-based model of healthcare across Europe was high on the agenda.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze